Daily Stock List
Pegasi Energy Resources Corp. (PGSI)
AwesomePennyPicks and FeedBlitz reported previously on Pegasi Energy Resources Corp. (PGSI), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Based in Tyler, Texas, Pegasi Energy Resources Corp. established to explore, develop, produce and sell natural gas and oil in the U.S. The Company is an independent organic growth-oriented energy enterprise engaged in the exploration and production of natural gas and oil via the development of a repeatable, low geological risk, high potential project in the active East Texas oil and gas region. Pegasi Energy Resources lists on the OTC Markets' OTCQB.
Pegasi is the successor entity to First Southern Crown Ltd.; a Texas limited partnership formed in December 2002 as a holding company for several operating subsidiaries. In March 2007, Pegasi Energy Resources formed as a Texas corporation; First Southern Crown Ltd. changed their name to Pegasi Energy Resources Corp. and converted into that Texas Corporation as part of a consolidation and corporate restructuring.
Currently, the Company holds interests in properties located in Marion and Cass County, Texas, home to the massive Rodessa oil field. Pegasi has designated their business strategy the "Cornerstone Project" or "CP". Their strategy is to identify and exploit resources in and adjacent to existing or indicated producing areas within the Rodessa field area.
Pegasi Energy Resources conducts their principal exploration and production operations via their wholly owned subsidiary, Pegasi Operating, Inc. They conduct additional operations through their wholly owned subsidiary: TR Rodessa, Inc. TR Rodessa operates a 40-mile natural gas pipeline and gathering system. The Company is currently using the system to transport their hydrocarbons to market. Excess capacity on this system is used to transport third-party hydrocarbons.
Pegasi has a leading acreage position in the highly active East Texas Cotton Valley trend. They have a 20,000+ gross (14,000+ net) acreage position in the Cornerstone Project. The Company has drilled five producing wells and has established a proved reserve base in the Rodessa field region with 21.4 bcfe of gross reserves and 1,166 mmcfe of current gross daily production. The Company has identified 109 locations on their present acreage position.
Furthermore, Pegasi has a considerable infrastructure in place. This includes the aforementioned 40-mile pipeline and established gathering system, and a salt-water disposal plant. The Company has ready access to a number of interstate pipelines and local end uses.
Pegasi Energy Resources Corp. (PGSI), closed Thursday's trading session at $0.82, down 2.38%, on 558,750 volume with 17 trades. The average volume for the last 60 days is 96,433 and the stock's 52-week low/high is $0.455/$1.09.
Colorado Gold Mines, Inc. (CGLD)
PennyStocks24, The Stock Psycho, Top Gun, Darth Trader, and StockMister reported this month on Colorado Gold Mines, Inc. (CGLD), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Headquartered in Las Vegas, Nevada, Colorado Gold Mines, Inc. is a development stage company that engages in the acquisition, exploration, development, and mining and processing of precious metal properties. Their operating interest includes the development stage Keeno Strike Silver and Gold Property located in the southern end of the Spring Mountains in the Yellow Pine Mining District of Southern Nevada. The mining claims are current with the United States Bureau of Land Management (BLM) and Clark County, Nevada.
The Keeno Strike Silver Property is favorably located near to existing infrastructure. This includes Jean, Nevada just off Interstate 15, a regional airport, rail, water supplies, telephone services, gas and electrical power. Moreover, there exist a number of existing historical mine workings in the area. An assortment of deposits and showings containing silver, gold and lead occur within a mile of the claims in the same kind of deposit exposed on the property.
The Keeno Strike Property is approximately 30 miles southwest of Las Vegas in the historical mining district known as the Goodsprings District. This District contains deposits of gold, silver, copper, cobalt nickel, zinc and lead. By the end of 1962, the Goodsprings district had yielded 109,000 tons of zinc, 147,000 tons of lead, 2,500 tons of copper, 900,500 ounces of gold, and 120,100,000 ounces of silver, 5 tons of cobalt and 1,200 ounces of platinum group metals (PGMs).
The Keeno property consists of 12 unpatented 20-acre lode-mining claims and one 5-acre mill site claim located in Clark County, Nevada. The claims are near the historical Monte Cristo Mine and the Keeno-Mint workings near Porter Wash in Clark County. Colorado Gold Mines earlier announced that they signed (in January 2013) an agreement granting the Company an option to purchase the Keeno Strike Gold and Silver Property.
Last week, Colorado Gold Mines announced that the optionor of the Keeno Strike Gold and Silver Property granted the Company a 30-day extension to meet the payment terms of the previously announced Option Agreement for the property.
Mr. William Lundy, Chief Executive Officer of Colorado Gold Mines, said, "We expect this 30 day extension for initial payment on the Keeno Strike property to be adequate to allow us to meet the terms of the agreement. We look forward to moving ahead with the project as planned."
Colorado Gold Mines, Inc. (CGLD), closed Thursday's trading session at $0.0244, up 6.09%, on 647,449 volume with 53 trades. The average volume for the last 60 days is 847,996 and the stock's 52-week low/high is $0.0201/$1.10.
Net Savings Link, Inc. (NSAV)
Investor Development Group reported earlier on Net Savings Link, Inc. (NSAV), and we highlight the Company, here at the QualityStocks Daily Newsletter.
Headquartered in Clearwater Beach, Florida, Net Savings Link, Inc. provides electronically deliverable sales incentives for the business market. They additionally provide enhanced web-based savings programs for the mass consumer market of individuals and families. They look to provide value through delivering one stop electronic access to savings, discounts, sales, coupons, specials and preferred member venues on those categories that consume the majority of today's net disposable income.
Their corporate mission is to serve as a total savings benefit destination that offers quality choices to the mass consumer markets of individuals, families, businesses, organizations, churches and on-line networks, from which multiple and distinct revenues can be generated.
The Company provides Electronically Deliverable Incentives (the EDI Program). Net Savings Link earns operating revenues from vendor provided commissions, end user membership fees, and individual product purchases. Products and services, such as groceries, dining, travel, shopping, wellness, and communications, are provided by preferred vendors, accessed via the Company, and subsequently provided to end users.
As members start to generate savings benefits from their website, Net Savings Link will at the same time monetize transactions from shared back end revenues with host organizations, end user membership fees, individual product purchase turnovers, and commissions generated from the broad spectrum of affiliate partners that are digitally connected, who offer major discounts to Net Savings Link users.
Net Savings Link uses a mix of three primary websites to target an extensive spectrum of customers. Their flagship site www.NetSavingsLink.com is a consumer based savings site that features savings on grocery's, dining, travel, shopping, fitness, electronics and more. This site has more than 51,000,000 products, as well as programs that provide revenue to the Company.
The Company's two business based sites are www.ThePerfectIncentive.com and www.TheSavingsSystem.com. They work together to provide the Incentive and Gift marketplace a turnkey guaranteed program. The NetSavingsLink.com website continues to expand its lure to new markets with the additions of the "Coupon Social" blog, Electronics, and Fitness & Weight Loss departments.
Net Savings Link, Inc. (NSAV), closed Thursday's trading session at $0.0002, even for the day, on 102,565 volume with 2 trades. The average volume for the last 60 days is 17,308,712 and the stock's 52-week low/high is $0.0001/$0.0349.
Stratex Oil & Gas Holdings, Inc. (STTX)
Wall Street Resources reported this week on Stratex Oil & Gas Holdings, Inc. (STTX), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
An independent energy company, Stratex Oil & Gas Holdings, Inc. focuses on the exploration, acquisition, and production of crude oil in the Bakken and Three Forks formations in North Dakota and Montana. The Company's strategy is to internally identify prospects, acquire lands including those prospects, and evaluate those prospects utilizing subsurface geology, geophysical data, and exploratory drilling. Stratex works to retain operations on their lands wherever possible to control the timing of the development of their leaseholds. Stratex Oil & Gas Holdings is based in Watertown, Connecticut.
The Company's oil and natural gas operations are primarily concentrated in two Rocky Mountain basins. These are the Williston Basin of North Dakota and Montana, and the Denver-Julesberg Basin of Colorado, Nebraska, and Kansas. The Company, in the Williston Basin, focuses on oil production from multiple zones including the Bakken Shale and Three Forks Sanish Formations. In the Denver-Julesberg Basin, they focus on the Niobrara Formations. In addition, Stratex owns an operating interest in a producing well in Roosevelt County, Montana.
Last week, the Company announced their participation in a new Bakken formation well in Divide County, North Dakota. The well is called Olson 35-26-1H. It is undergoing drilling and operation by Mountainview Energy, based in Cut Bank, Montana. The Olson 35-26-1H was spud on January 5, 2013; it is currently on confidential status. Stratex Oil & Gas anticipates receiving production data from their operating partner Mountainview Energy soon.
Moreover, last week, Stratex announced the reworking of one of their three Kansas wells. Central Operating, their operating partner, is installing a PC pump to increase the disposal of salt water and increase the oil cut production of their Thecla Haas well in Lane County, Kansas. Central operating expects this work over to increase the oil production of the Thecla Haas well right away.
Today, Stratex Oil & Gas announced that the Company has leasehold interests in 60,000 gross and 6,000 net acres in Sioux County, Nebraska. They acquired this acreage with the anticipation that an unconventional shale play may develop and that they could participate as a non-operating working interest (WI) partner.
Stratex Oil & Gas Holdings, Inc. (STTX), closed Thursday's trading session at $1.47, up 1.38%, on 214,701 volume with 145 trades. The average volume for the last 60 days is 57,239 and the stock's 52-week low/high is $0.2857/$2.90.
Bergio International, Inc. (BRGO)
PennyStocks24 reported recently on Bergio International, Inc. (BRGO), OTCPicks, PennyTrader Publisher, Penny Dreamers, Greenbackers, Pennybuster did earlier, and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Bergio International, Inc. is a leading jeweler and they are creating one of the world's largest diversified jewelry designers and manufacturers through acquisitions and consolidation. The Company sells their jewelry to distributors, retailers, and other wholesalers throughout the United States. Bergio has manufacturing control over their line due to having a manufacturing facility in New Jersey and subcontracts with other facilities (U.S. and Italy). Bergio International has their headquarters in Fairfield, New Jersey.
Currently, the Company sells their jewelry to approximately 50 jewelry retailers across America. Bergio offers a variety of products created from precious metals. These include gold, platinum, Karat gold, diamonds, and other precious stones. They offer a collection of charms, crosses, and other add-on pieces; fashion jewelry, such as necklaces, pendants, earrings, bracelets and rings; a couture line; and a bridal line, which consists of wedding sets, engagement rings, and wedding bands for men and women.
Three separate collections exist under the Bergio umbrella. These are Bergio Fine, Bergio Bridal and Bergio Couture. Bergio Fine consists of 18kt gold and sterling silver with diamond collections. Bergio Bridal is a contemporary collection of engagement rings, eternity bands and bridal sets in platinum and 18kt gold. Bergio Couture is limited edition offerings.
Earlier this month, Bergio International announced year-end results for 2012. The Company showed a profit from operations of $73,186. This represents an increase of approximately $314,193 (130 percent) from the loss of $241,000 from the same period a year prior. They reported an increase in revenue of 24.47 percent for total net sales of $2,017,614 for the year ended December 31, 2012. This is in comparison to $1,621,000 for the year ended December 31, 2011.
This week, Bergio International announced that the Company is expanding the brand into ShopNBC starting May 7, 2013. ShopNBC is a major television-shopping network for high-end jewelry and other luxury goods. ShopNBC is a multichannel electronic retailer that has a strong presence in home shopping through television and other avenues such as online, mobile, and social media.
Bergio International, Inc. (BRGO), closed Thursday's trading session at $0.0028, up 21.74%, on 41,393,518 volume with 203 trades. The average volume for the last 60 days is 20,752,013 and the stock's 52-week low/high is $0.0005/$0.0135.
Max Sound Corp. (MAXD)
Greenbackers reported recently on Max Sound Corp. (MAXD), Investor Development Group did earlier, and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
A development stage company, Max Sound Corp. focuses on developing and launching audio technology software. Founded in 2005, the Company is a provider of HD Audio to the multi-media industry. They formerly went by the name So Act Network, Inc. They changed their corporate name to Max Sound Corp. in March of 2011. Max Sound's shares trade on the OTC Bulletin Board.
Mr. John Blaisure is the President and Chief Executive Officer of Max Sound. Before joining the Company, Mr. Blaisure was the Founder, President, and CEO of Effective Network Systems (ENS). The Inventor of the Company's MAX·D technology is Mr. Lloyd Trammel. He was voted by his peers, at Electronic Musician Magazine, as one the worlds top four audio engineers and sound-designers. Mr. Trammell was influential in helping create MIDI, the Musical Instrument Digital Interface. MIDI is an electronic musical instrument industry specification. It enables a broad array of digital musical instruments, computers and other related devices to connect and communicate with each other.
In May of 2010, Max Sound acquired the global rights to all fields of use for Max Sound HD Audio technology. In November of 2010, the Company opened their post-production facility for Max Sound HD Audio in Santa Monica, California.
In February of 2011, after many successful demonstrations of their Max Sound Audio technology to assorted multi-media industry company executives, the Company made a decision to shift the focus of the Company to the Max Sound HD Audio technology. Max Sound is in negotiations with a number of multi-media companies that will use the Company's HD Audio solution in the future.
Max Sound's intention is to offer their products and services to diverse industries. These include consumer electronics, motion picture, broadcasting, video game, recording, cell phone, Internet, and Voice over Internet Protocol (VOIP) applications.
Max Sound (MAX·D) is an audio process. This process significantly improves sound quality without increasing file size. MAX·D is a dynamic process; it is not a static process like other audio technologies. MAX·D makes it possible for electronic devices to hold more content and use less data.
Max Sound Corp. (MAXD), closed Thursday's trading session at $0.248, down 1.20%, on 560,600 volume with 72 trades. The average volume for the last 60 days is 217,727 and the stock's 52-week low/high is $0.186/$0.58.
Focus Graphite, Inc. (FMS.V)
Today we are highlighting Focus Graphite, Inc. (FMS.V), here at the QualityStocks Daily Newsletter.
Listed on the TSX.V, Focus Graphite, Inc. is a mid-tier junior mining Development Company, a technology solutions supplier, and a business innovator. They are the owner of the Lac Knife graphite deposit located in the Côte-Nord region of northeastern Québec. A technology-oriented organization, Focus Graphite invests in the development of graphene applications and patents through Grafoid, Inc. Focus Graphite's goal is to assume an industry leadership position through becoming a low-cost producer of technology-grade graphite. The Company is based in Ottawa, Ontario.
Their Lac Knife project hosts an NI 43-101 compliant Measured and Indicated mineral resource of 4.972 Mt grading 15.7 percent carbon as crystalline graphite with an additional Inferred mineral resource of 3.000 Mt grading 15.6 percent crystalline graphite. On October 29, 2012, Focus released the results of a Preliminary Economic Analysis (PEA) of the Lac Knife project that demonstrates the project has excellent potential to become a producer of graphite.
Yesterday, Focus Graphite reported the commissioning of their pilot plant and the start-up of circuit testing for the production of high-grade graphite concentrates from their wholly owned Lac Knife graphite project. The main goals of the pilot plant test work are to confirm the results from Phase II bench scale Locked Cycle Tests (LCT); to assess the technical viability and operational performance of the processing plant design; to generate tailings for environmental testing, and to produce a spectrum of graphite raw materials for customer assessments and for further upgrading.
In addition, this week, Focus Graphite on behalf of Grafoid announced the signing of a two-year R&D agreement between Grafoid and the University of Waterloo to investigate and develop a graphene-based composite for electrochemical energy storage for the automotive and/or portable electronics sectors.
Mr. Gary Economo, President and CEO of Focus Graphite and Grafoid, stated that the objective of the agreement is to research and develop patentable applications by means of Grafoid's unique investment, which derives graphene from raw, graphite ore to target specialty high value graphene derivatives ranging from sulfur graphene to nanoporous graphene foam.
Focus Graphite, Inc. (FMS.V), closed Thursday's trading session at $0.50, down 7.41%, on 466,879 volume. The stock's 52-week low/high is $0.45/$1.10.
TransAct Energy Corp. (TEGY)
Real Pennies, TopStockAnalysts, ProfitableTrading, Street Insider, Penny Stock Buzz, Barchart, StreetAuthority Daily, and FeedBlitz reported recently on Universal Bioenergy, Inc. (UBRG), and today we are reporting on TransAct Energy Corp. (TEGY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
TransAct Energy Corp. engages in the development, production, management and conservation of energy through sustainable projects. The Company focuses on emissions free energy produced from carbonaceous waste, as well as Geothermal, Solar and Wind. Their present focus is waste technologies and resources. Established in 2006, TransAct Energy has their corporate headquarters in San Antonio, Texas. The Company's shares trade on the OTCQB.
In 2010, the Company launched their "Energy from Waste" division; they formed relations with over a dozen international municipalities. In 2011, they engaged the world's only emissions free energy from waste technology.
Concerning Waste, TransAct Energy's business is the building/owning/operating (BOO) of the only, profitable, emissions free, carbon negative, industrial scale, waste processing plant. It produces fuel (diesel, gasoline, and aviation), LPG (liquefied petroleum gas), Carbon Black and recycled materials (metal, nylon, cotton) from municipal solid waste (MSW), medical waste, agricultural waste and industrial waste.
In February, TransAct Energy released terms of their Joint Development Agreement (JDA) announced earlier with Mr. Bruce Hutchon, Utopial Limited and Halfuel Limited. The JDA specifies the formation of a joint corporation where Hutchon's transfers his proprietary emissions free energy-from-waste technology, the 20 tonne operating plant and all associated research. TransAct Energy develops/transfers a five-year Business plan, executes the same and causes $100 Million USD to be available to the newly formed company to build a plant in Scotland of approximately the same value.
In addition, in February, TransAct Energy announced a Letter of Intent (LOI) between Malcolm Brown Ltd. and TransAct Energy from Waste (TEFW), a subsidiary of TransAct Energy. Brown will secure long-term supply contracts for prepared municipal solid waste (MSW) in the form of refuse derived fuel and specified recovered fuel that are MSW that has had non-combustibles removed. The expectation is that these contracts will be secured for the fall 2013 opening of the Scotland TEFW plant.
Today,TransAct Energy Corp. (TEGY), closed Thursday's trading session at $0.12, up 140.00%, on 5,073,835 volume with 721 trades. The average volume for the last 60 days is 6,268 and the stock's 52-week low/high is $0.0086/$0.078.
Advaxis, Inc. (ADXS)
The QualityStocks Daily Newsletter would like to spotlight Advaxis, Inc. (ADXS). Today, Advaxis, Inc. closed trading at $0.074, off by 7.50%, on 2,044,988 volume with 100 trades. The stock’s average daily volume over the past 60 days is 3,386,617, and its 52-week low/high is $0.0275/$0.155.
Advaxis, Inc. reported today that Senior VP, Chief Legal, and Business Development Officer for the company, Daniel J. O’Connor, will present at what is the biggest global event for the biotechnology and pharmaceutical industries, the BIO International Convention, this April 22 at 3:00 p.m., in Chicago's new McCormick Place Convention Center. O’Connor will go over details of the company's lead drug candidate, ADXS-HPV, updated data on which is also set to be released at the 2013 American Society of Clinical Oncology Annual Meeting in June.
Advaxis, Inc. (ADXS) is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.
The company has more than fifteen distinct constructs in various stages of development, all of which are involved in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.
Advaxis’ lead construct, ADXS-HPV, is currently in Phase 2 clinical development for recurrent/refractory and advanced cervical cancer, CIN 2/3, and HPV caused head and neck cancers. This important construct was recognized as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence (ViE) Awards by the vaccine industry and the journal Expert Reviews of Vaccines.
The estimated global market for immunotherapies is projected to exceed $37.2B by 2012, with cancer vaccines forecast to grow into an $8B market. Protected by 77 issued and pending patents, Advaxis is extremely well positioned to capitalize on the burgeoning opportunities in the healthcare sector as it advances the development of next-generation treatments for today’s most challenging diseases. Disclaimer
Advaxis, Inc. Company Blog
Advaxis, Inc. News:
Advaxis to Present at the BIO International Convention
Advaxis to Report 12-Month Survival from Its Phase 2 Study of ADXS-HPV in Women with Recurrent/Refractory Cervical Cancer
Advaxis Announces Abstract Accepted for Oral Presentation at SITC Cancer Immunotherapy Clinical Trials Workshop
The Aristocrat Group Corp. (ASCC)
The QualityStocks Daily Newsletter would like to spotlight The Aristocrat Group Corp. (ASCC). Today, The Aristocrat Group Corp. closed trading at $0.518, up 3.60%,on 48,456 volume with 17 trades. The stock’s average daily volume over the past 60 days is 57,922, and its 52-week low/high is $0.25/$1.25.
The Aristocrat Group Corp. (ASCC) is a brand management company focused on providing premiere luxury goods through continual innovation. Luxuria Brands, a subsidiary of The Aristocrat Group, has been established to identify and promote unique brands that have mass market appeal across a diverse demographic.
Luxuria Brands is primarily concentrated on distilled spirits industries, with an initial focus on Vodka branding and marketing. The worldwide distilled spirits market is currently worth about $263 billion. In the U.S. alone, Vodka sales between 2004 and 2009 grew 25% from 13.9 million cases to 58.4 million cases. The clear liquor now accounts for almost a third of all distilled spirits consumed and continues to rise in popularity.
The Aristocrat Group is also pursuing opportunities in the women’s lifestyle industry. The World Bank recently estimated that the earning power of women will reach $18 trillion by 2014, which is twice the estimated 2014 GDP of China and India combined. The Aristocrat Group is working to bring fresh, innovative prenatal and postpartum solutions to women who are looking for a more comprehensive approach to wellness.
The Aristocrat Group is leveraging the marketing strengths of its team of experts to grow boutique products into powerful, recognizable brands. The company aims to take a leadership position in multiple growing markets that offer opportunities for partnership, sponsorship, and brand awareness activities. The Aristocrat Group is leveraging the marketing strengths of its team of experts to grow boutique products into powerful, recognizable brands. Disclaimer
The Aristocrat Group Corp. Company Blog
The Aristocrat Group Corp. News:
ASCC Looks to Apple, Social Media to Promote New Brands
ASCC Seeks to Add New Brands Through Mergers & Acquisitions
ASCC to Redefine Spirits Market
VIASPACE, Inc. (VSPC)
The QualityStocks Daily Newsletter would like to spotlight VIASPACE, Inc. (VSPC). Today, VIASPACE, Inc. closed trading at $0.0155, up 3.33%, on 219,209 volume with 7 trades. The stock’s average daily volume over the past 60 days is 845,722, and its 52-week low/high is $0.0013/$0.0158.
VIASPACE, Inc. (VSPC) is focused on growing renewable Giant King™ Grass as a low-carbon fuel for clean electricity generation and environmentally friendly energy pellets, as well as a feedstock for bio-methane production, green cellulosic biofuels, biochemical, and biomaterials. A high-yield, low-cost feedstock, Giant King Grass meets the cost targets of green energy applications while maintaining a carbon neutral profile.
The highest yielding biomass crop in the world, Giant King Grass can grow in a variety of soil conditions and does not compete with food crops. Once Giant King Grass is established, it can be harvested at 3-5 feet tall every 45 to 60 days or at 14 feet tall twice a year. This incredibly high rate of growth provides a continual supply of biomass year-round, enabling strategically located power plants to operate 24 hours a day regardless of the current season.
VIASPACE provides Giant King™ Grass seedlings and technical expertise to qualified projects. The company also plans to serve as a project developer or co-developer for power plant or pellet mill projects, together with local partners that have land and require electricity, heat, pellets, biogas, or biofuels. VIASPACE and its partners are capable of delivering an integrated Giant King Grass plantation and biomass power plant project in just 24 months.
The excellent energy characteristics of Giant King Grass and its ability to be harvested multiple times each year enable and energy output yield that is much higher than other crops . This superior feedstock offers material productivity benefits at remarkable costs for energy production, biofuels, and biomaterials. Giant King Grass is currently being grown in the United States, Virgin Islands, China, and other areas. Disclaimer
VIASPACE, Inc. Company Blog
VIASPACE, Inc. News:
VIASPACE and AGRICORP Partnership on Giant King Grass in Nicaragua: 12 MW Biomass Power Plant Targeted
VIASPACE Insiders Extend Lock-up of Shares
VIASPACE Chairman Interviews with CEONEWS.Tv Regarding Business Dynamics and Recent Corporate Milestones
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $0.22, even with yesterday's close, on 4,300 volume with 1 trade. The stock’s average daily volume over the past 60 days is 15,093, and its 52-week low/high is $0.18/$1.82.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise Investments Announces Results for Fiscal Year 2012
GlobalWise Investments, Inc. Completes $3.0 Million Private Placement
GlobalWise Comments on Recent Balance Sheet Improvements, Channel Partners and Market Opportunities
Advaxis, a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases, announced today that Daniel J. O’Connor, Senior VP, Chief Legal, and Business Development Officer at Advaxis, will be presenting at the BIO International Convention (BIO 2013) in Chicago, IL, later this week.
On April 22 at 3:00pm, Mr. O’Connor will provide a review of the progress of ADXS-HPV, Advaxis’ lead drug candidate in Phase 2 clinical development for recurrent/refractory cervical cancer. Updated data regarding this exciting compound will be disclosed at the 2013 American Society of Clinical Oncology Annual Meeting in June.
Recognized as the largest global event for biotechnology and pharmaceutical industries, the BIO International Convention attracts many of the biggest names across all major continents. This year’s convention was organized to provide valuable networking and partnering opportunities, as well as generate insights and inspirations on current trends that are essential in the development of innovative and better technologies for the future.
For more information, visit www.Advaxis.com
GlobalWise Investments, through its Intellinetics subsidiary, is the developer of world-class enterprise content management (ECM) Intellivue software, available as a stand-alone system or through advanced cloud processing. The company offers a comprehensive set of industry-specific solutions designed to give government and commercial organizations of all types complete control over critical documents that can otherwise be lost in the shuffle of high-volume paperwork. Their cutting-edge cloud based solution in particular offers authorized users access (protected by over 99 levels of security) to needed information from anywhere on the planet, any time of the day or night.
According to Gartner, the ECM industry is expected to exceed $5.7 billion by 2014, with a compounded annual growth rate of over 10%. There is a vast unmet need for ECM functionality in Tier 3 and Tier 4 companies, the small to medium sized organizations that represent the primary target of GlobalWise, with virtually no other significant providers focused on that market. The convergence of technology and cost makes Intellinetics software affordable to such companies, with the industry’s first mobile-enabled (Android, iPhone) ECM platform. The company’s open cloud solution and Channel/OEM distribution approach puts them in a unique position to capture this large and unserved market. In addition, leading hardware vendors, such as Samsung, Lexmark, and Dell, are actively leveraging the GlobalWise/Intellinetics model by integrating their hardware into the Intellivue cloud platform.
GlobalWise offers a lower cost delivery model, the advantages of which are summarized by the company’s President and CEO, William “BJ” Santiago: “Many in the industry have called our flagship software a ‘channel changer’ because our user-friendly model is similar to the traditional per click charge standard, but introduces a fixed cost model that appeals to a wider customer base.” The company also differentiates itself with far quicker response times, of great importance to Tier 3 and 4 organizations, with installations available in days instead of weeks or months.
For additional information on GlobalWise and its subsidiary, Intellinetics, visit www.GlobalWiseInvestments.com
The importance of the work being done at VistaGen Therapeutics, developers of stem-cell based bioassay early-warning systems for determining possible toxicity of drug candidates, can be seen in the clinical disasters occasionally experienced by major players in the pharmaceutical industry. A recent article (http://dtg.fm/v3V4) by Valorie Sands in Minyanville, an Internet-based financial media and publishing company, gives an idea of the risks pharmacy companies face, and the need for better and earlier testing.
The article points to the 2010 withdrawal by Pfizer of Thelin (sitaxentan), a medication for treating pulmonary arterial hypertension that had been approved for marketing in Europe, Canada, and Australia, and was undergoing final clinical trials in the U.S., when liver toxicity claimed two lives. In 2008, Pfizer had paid roughly $195 million in a cash tender offer to acquire Encysive Pharmaceuticals to get the drug, which had generated sales of over $44 million for Pfizer in the 9 months prior to its withdrawal.
Another example referred to in the article was a class of highly effective anticancer drugs called anthracycines. In spite of their effectiveness in the treatment of lung cancer, breast cancer, lymphomas, leukemias, and other types of cancers, the use of these drugs is now considerably limited due to the later discovery of significant cardiotoxicity associated with anthracycines.
Overall, toxicity issues end up affecting many new drugs, often late in testing, or even when they have made it all the way to market. The risk is not only to the physical health of patients, but also to the fiscal health of the companies that have invested hundreds of millions in a drug’s development. VistaGen proposes a solution to the problem through its unique Human Clinical Trials in a Test Tube stem cell based platform designed to provide superior heart and liver toxicity testing right in the laboratory, well before clinical trials or market exposure.
For additional information, visit www.VistaGen.com
Today, Neuralstem announced it has received FDA approval to commence a Phase II trial using NSI-566 spinal cord-derived human neural stems cells to treat amyotrophic lateral sclerosis, commonly known as ALS or Lou Gehrig’s disease. The Phase II dose escalation and safety trial will expand two centers: Emory University Hospital in Atlanta, Ga., where Phase I was recently completed; and ALS Clinic at the University of Michigan Health System in Ann Arbor, Mich. Both expansions are subject to approval by each institution’s Institutional Review Board.
This trial is designed to treat up to 15 patients in five different dosing cohorts. All patients will be ambulatory and reside within close geographic proximity to the research center at which they will be participating. The first 12 patients in the trial will receive injections in the cervical region of the spinal cord only, where the stem cells could help preserve breathing function. The last three patients will receive both surgical and lumbar injections.
During Phase I of the trial, it was demonstrated that the therapy appeared to interrupt progression of ALS in one subgroup of patients over a long time period. The goal of the Phase II trial is to obtain the maximum tolerated dose using the same route of administration as in the Phase I trial, which was through direct injections into the spinal cord’s gray matter. Due to the excellent safety and tolerability demonstrated in the Phase I trial, Neuralstem will be able to proceed more aggressively in Phase II. The company began with just five injection sites per patient in Phase I, advancing to a minimum of 15 injections of 100,000 cells each. The company will advance up to a maximum of 40 injections in Phase II, with 400,000 cells per injection based on safety.
Finally, Neuralstem will add another center, the University of Michigan, where the trial will be conducted under the direction of study principal investigator Dr. Eva Feldman and site investigator Dr. Parag Patil. The trial will also continue at Emory, where it originated, under the direction of site principal investigator Dr. Jonathan Glass.
“We are eager to advance this trial to the next phase, using considerably more cells to assess the impact and safety,” said Dr. Eva Feldman, MD, Ph.D., director of the A. Alfred Taubman Medical Research Institute and director of research of the ALS Clinic at the University of Michigan Health System. Dr. Feldman serves as an unpaid consultant to Neuralstem.
For more information about this trial, or for information about Neuralstem, visit www.neuralstem.com
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) to Present at the BIO International Convention
- Consorteum Holdings, Inc. (CSRH) Enters Partnership Agreement With KO Entertainment, Inc.
- Cardium Therapeutics, Inc. (CXM) Receives ISO Certification for Excellagen
- GlobalWise Investments, Inc. (GWIV) CEO to Speak at Technology United Executive Conference
- International Stem Cell Corp. (ISCO) Announces Fourth Quarter 2012 Financial Results and Provides Business Update
- Loans4Less.com, Inc. (LFLS) Ranked in List as a Top Residential Loan Originator 2012
- Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services
- Rainbow Coral Corp. (RBCC) Nears Deal With Leading Genetic Testing Lab
- Soul and Vibe Interactive Inc. (SOUL) to Pursue Business Development Deals at Game Connection Conference in San Francisco
- The Aristocrat Group Corp. (ASCC) Looks to Apple, Social Media to Promote New Brands
- The Guitammer Company Inc. (GTMM) Joins D-Tools Manufacturer Vantage Point (MVP) Program
- VentriPoint Diagnostics Ltd. (VPTDF) Receives CE Mark for Major Expansion of Its VMS™ Platform for Right Heart Analysis
- Viaspace, Inc. (VSPC) and AGRICORP Partnership on Giant King Grass in Nicaragua: 12MW Biomass Power Plant Targeted
- VistaGen Therapeutics, Inc. (VSTA) Announces $36 Million Strategic Financing Agreement